Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton F Stewart

Showing results (161-170 of 220) with videos related to

Pageof 22
Sort By:
Cancer|May 12, 2017
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabineSeth E Karol, Wenjian Yang, Colton Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group StudyNajat C Daw, Wayne L Furman, Clinton F Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Topotecan is active against Wilms' tumor: results of a multi-institutional phase II studyMonika L Metzger, Clinton F Stewart, Burgess B Freeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium studyMaryam Fouladi, Clinton F Stewart, James Olson, et al.
Molecular Cancer Therapeutics|June 16, 2022
Combination of Ribociclib and Gemcitabine for the Treatment of MedulloblastomaAllison Pribnow, Barbara Jonchere, Jingjing Liu, et al.
Molecular Cancer Therapeutics|December 6, 2008
IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expressionShannon F Rosati, Regan F Williams, Lindsey C Nunnally, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium studyLars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Cancer Cell|April 7, 2016
Medulloblastoma Genotype Dictates Blood Brain Barrier PhenotypeTimothy N Phoenix, Deanna M Patmore, Scott Boop, et al.
Cancer|January 19, 2012
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patientsAnthony M Christensen, Jennifer L Pauley, Alejandro R Molinelli, et al.
Cancer|April 21, 2012
Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicityIbrahim Qaddoumi, Catherine A Billups, Michael Tagen, et al.
Pageof 22

Showing results (161-170 of 220) with videos related to

Sort By:
Pageof 22
Cancer|May 12, 2017
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabineSeth E Karol, Wenjian Yang, Colton Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group StudyNajat C Daw, Wayne L Furman, Clinton F Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Topotecan is active against Wilms' tumor: results of a multi-institutional phase II studyMonika L Metzger, Clinton F Stewart, Burgess B Freeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium studyMaryam Fouladi, Clinton F Stewart, James Olson, et al.
Molecular Cancer Therapeutics|June 16, 2022
Combination of Ribociclib and Gemcitabine for the Treatment of MedulloblastomaAllison Pribnow, Barbara Jonchere, Jingjing Liu, et al.
Molecular Cancer Therapeutics|December 6, 2008
IFN-beta sensitizes neuroblastoma to the antitumor activity of temozolomide by modulating O6-methylguanine DNA methyltransferase expressionShannon F Rosati, Regan F Williams, Lindsey C Nunnally, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium studyLars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Cancer Cell|April 7, 2016
Medulloblastoma Genotype Dictates Blood Brain Barrier PhenotypeTimothy N Phoenix, Deanna M Patmore, Scott Boop, et al.
Cancer|January 19, 2012
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patientsAnthony M Christensen, Jennifer L Pauley, Alejandro R Molinelli, et al.
Cancer|April 21, 2012
Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicityIbrahim Qaddoumi, Catherine A Billups, Michael Tagen, et al.
Pageof 22